Organization
Argorna Pharmaceuticals
2 clinical trials
Clinical trial
Evaluate the Safety and Immunogenicity of a SARS-CoV-2 mRNA Vaccine (RBMRNA-405) as a Booster in Chinese Adults & OlderStatus: Completed, Estimated PCD: 2022-06-13
Clinical trial
A Phase I/II, Randomized, Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (RBMRNA-176) in Healthy Adults Aged 18 Years and OlderStatus: Completed, Estimated PCD: 2022-09-01